415 CAPITAL
Deals on record
4
Common Fundraising Type
Series B
Medical Device Development • Percutaneous Ventricular Assist Device
Supira Medical, Inc. is developing the Supira System, a percutaneous ventricular assist device (pVAD) designed to provide hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients.
Medical technology • Clot removal
Endovascular Engineering, Inc. develops the Hēlo Thrombectomy System, a novel technology for removing clots in venous thromboembolism (VTE).
Microvascular Obstruction • Heart attack
CorFlow Therapeutics AG develops and validates the CoFl system for diagnosing and treating Microvascular Obstruction (MVO) in heart attack patients.
Medical Device Development • Percutaneous Ventricular Assist Device
Supira Medical, Inc. is developing the Supira System, a percutaneous ventricular assist device (pVAD) designed to provide hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients.